Add to Watchlist
View Current for ADAP
View SuperFeed for ADAP
View Charts for ADAP
Add or remove $ADAP from your watchlists:
Hang tight! We're updating your watchlist data. This might take a minute...
You have not created a stock watchlist.
Create one now to track $ADAP!
Done
Manage Watchlists
Adaptimmune Therapeutics Plc
Health Care
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United St…
more
Conversation Volume
Last 60 days
There is not enough conversation volume about this stock
Key Opinion Leaders
Strongest 30-day focus on $ADAP by total mentions
Real-time Chart
Price Chart for $ADAP
Conviction History
Bullish vs Bearish Conviction over the last 30 days.
This color denotes Market Hours (US/Eastern)
There is not enough conversation volume about this stock
Thread Explorer
Explore popular threads around $ADAP
There are no threads for this stock
Chart Explorer
Explore recent charts, graphs, and media
There are no charts for this stock
Rarely do we see this kind of divergence between value ($SPYV = black line) and growth ($SPYG = red line). Check it out this 5 year chart...
Go to Chart Explorer
Latest News
Get the latest breaking news from the community
There is no recent news for this stock
Loading news, hang tight...
Google Search Trends - Past 12 months
Instantly visualize search trends for this specific symbol
Today
Past 7 days
Past 30 days
Past 60 days
Custom
Company Profile
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; co-development collaboration agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Market Cap Type: Small
Close
Date,Time,Temperature
2024-04-11,15,0.12800000607967377
2024-04-11,16,0
2024-04-11,17,0
2024-04-11,18,0
2024-04-11,19,0
2024-04-11,20,0
2024-04-11,21,0
2024-04-11,22,0
2024-04-11,23,0
2024-04-12,0,0
2024-04-12,1,0
2024-04-12,2,0
2024-04-12,3,0
2024-04-12,4,0
2024-04-12,5,0
2024-04-12,6,0
2024-04-12,7,0
2024-04-12,8,0
2024-04-12,9,0.125
2024-04-12,10,0
2024-04-12,11,0
2024-04-12,12,0
2024-04-12,13,0
2024-04-12,14,0
2024-04-12,15,0
2024-04-12,16,0.12800000607967377
2024-04-12,17,0
2024-04-12,18,0
2024-04-12,19,0
2024-04-12,20,0
2024-04-12,21,0
2024-04-12,22,0
2024-04-12,23,0
2024-04-13,0,0
2024-04-13,1,0
2024-04-13,2,0
2024-04-13,3,0
2024-04-13,4,0
2024-04-13,5,0
2024-04-13,6,0
2024-04-13,7,0
2024-04-13,8,0
2024-04-13,9,0
2024-04-13,10,0
2024-04-13,11,0
2024-04-13,12,0
2024-04-13,13,0
2024-04-13,14,0
2024-04-13,15,0
2024-04-13,16,0
2024-04-13,17,0
2024-04-13,18,0
2024-04-13,19,0
2024-04-13,20,0
2024-04-13,21,0
2024-04-13,22,0
2024-04-13,23,0
2024-04-14,0,0
2024-04-14,1,0
2024-04-14,2,0
2024-04-14,3,0
2024-04-14,4,0
2024-04-14,5,0
2024-04-14,6,0
2024-04-14,7,0
2024-04-14,8,0
2024-04-14,9,0
2024-04-14,10,0
2024-04-14,11,0
2024-04-14,12,0
2024-04-14,13,0
2024-04-14,14,0
2024-04-14,15,0
2024-04-14,16,0
2024-04-14,17,0
2024-04-14,18,0
2024-04-14,19,0
2024-04-14,20,0
2024-04-14,21,0
2024-04-14,22,0
2024-04-14,23,0
2024-04-15,0,0
2024-04-15,1,0
2024-04-15,2,0
2024-04-15,3,0
2024-04-15,4,0
2024-04-15,5,0
2024-04-15,6,0
2024-04-15,7,0
2024-04-15,8,0
2024-04-15,9,0
2024-04-15,10,0
2024-04-15,11,0
2024-04-15,12,0
2024-04-15,13,0
2024-04-15,14,0
2024-04-15,15,0
2024-04-15,16,0
2024-04-15,17,0
2024-04-15,18,0
2024-04-15,19,0
2024-04-15,20,0
2024-04-15,21,0
2024-04-15,22,0
2024-04-15,23,0
2024-04-16,0,0
2024-04-16,1,0
2024-04-16,2,0
2024-04-16,3,0
2024-04-16,4,0
2024-04-16,5,0
2024-04-16,6,0
2024-04-16,7,0
2024-04-16,8,0
2024-04-16,9,0
2024-04-16,10,0
2024-04-16,11,-0.41990000009536743
2024-04-16,12,0
2024-04-16,13,0
2024-04-16,14,0
2024-04-16,15,0
2024-04-16,16,0
2024-04-16,17,0
2024-04-16,18,0
2024-04-16,19,0
2024-04-16,20,0
2024-04-16,21,0
2024-04-16,22,0
2024-04-16,23,0
2024-04-17,0,0
2024-04-17,1,0
2024-04-17,2,0
2024-04-17,3,0
2024-04-17,4,0
2024-04-17,5,0
2024-04-17,6,0
2024-04-17,7,0
2024-04-17,8,0
2024-04-17,9,0
2024-04-17,10,0
2024-04-17,11,0
2024-04-17,12,0
2024-04-17,13,0
2024-04-17,14,0
2024-04-17,15,0
2024-04-17,16,0
2024-04-17,17,0
2024-04-17,18,0
2024-04-17,19,0
2024-04-17,20,0
2024-04-17,21,0
2024-04-17,22,0
2024-04-17,23,0
2024-04-18,0,0
2024-04-18,1,0
2024-04-18,2,0
2024-04-18,3,0
2024-04-18,4,0
2024-04-18,5,0
2024-04-18,6,0
2024-04-18,7,0
2024-04-18,8,0
2024-04-18,9,0
2024-04-18,10,0
2024-04-18,11,0
2024-04-18,12,0
2024-04-18,13,0
2024-04-18,14,0
2024-04-18,15,0
2024-04-18,16,0
2024-04-18,17,0
2024-04-18,18,0
2024-04-18,19,0
2024-04-18,20,0
2024-04-18,21,0
2024-04-18,22,0
2024-04-18,23,0
2024-04-19,0,0
2024-04-19,1,0
2024-04-19,2,0
2024-04-19,3,0
2024-04-19,4,0
2024-04-19,5,0
2024-04-19,6,0
2024-04-19,7,0
2024-04-19,8,0
2024-04-19,9,0
2024-04-19,10,0
2024-04-19,11,0.12800000607967377
2024-04-19,12,0
2024-04-19,13,0
2024-04-19,14,0
2024-04-19,15,0
2024-04-19,16,0
2024-04-19,17,0
2024-04-19,18,0
2024-04-19,19,0
2024-04-19,20,0
2024-04-19,21,0
2024-04-19,22,0
2024-04-19,23,0
2024-04-20,0,0
2024-04-20,1,0
2024-04-20,2,0
2024-04-20,3,0
2024-04-20,4,0
2024-04-20,5,0
2024-04-20,6,0
2024-04-20,7,0
2024-04-20,8,0
2024-04-20,9,0
2024-04-20,10,0
2024-04-20,11,0
2024-04-20,12,0
2024-04-20,13,0
2024-04-20,14,0
2024-04-20,15,0
2024-04-20,16,0
2024-04-20,17,0
2024-04-20,18,0
2024-04-20,19,0
2024-04-20,20,0
2024-04-20,21,0
2024-04-20,22,0
2024-04-20,23,0
2024-04-21,0,0
2024-04-21,1,0
2024-04-21,2,0
2024-04-21,3,0
2024-04-21,4,0
2024-04-21,5,0
2024-04-21,6,0
2024-04-21,7,0
2024-04-21,8,0
2024-04-21,9,0
2024-04-21,10,0
2024-04-21,11,0
2024-04-21,12,0
2024-04-21,13,0
2024-04-21,14,0
2024-04-21,15,0
2024-04-21,16,0
2024-04-21,17,0
2024-04-21,18,0
2024-04-21,19,0
2024-04-21,20,0
2024-04-21,21,0
2024-04-21,22,0
2024-04-21,23,0
2024-04-22,0,0
2024-04-22,1,0
2024-04-22,2,0
2024-04-22,3,0
2024-04-22,4,0
2024-04-22,5,0
2024-04-22,6,0
2024-04-22,7,0
2024-04-22,8,0
2024-04-22,9,0
2024-04-22,10,0
2024-04-22,11,0
2024-04-22,12,0
2024-04-22,13,0
2024-04-22,14,0
2024-04-22,15,0
2024-04-22,16,0
2024-04-22,17,0
2024-04-22,18,0
2024-04-22,19,0
2024-04-22,20,0
2024-04-22,21,0
2024-04-22,22,0
2024-04-22,23,0
2024-04-23,0,0
2024-04-23,1,0
2024-04-23,2,0
2024-04-23,3,0
2024-04-23,4,0
2024-04-23,5,0
2024-04-23,6,0
2024-04-23,7,0
2024-04-23,8,0
2024-04-23,9,0
2024-04-23,10,0
2024-04-23,11,0
2024-04-23,12,0
2024-04-23,13,0
2024-04-23,14,0
2024-04-23,15,0
2024-04-23,16,0
2024-04-23,17,0
2024-04-23,18,0
2024-04-23,19,0
2024-04-23,20,0
2024-04-23,21,0
2024-04-23,22,0
2024-04-23,23,0
2024-04-24,0,0
2024-04-24,1,0
2024-04-24,2,0
2024-04-24,3,0
2024-04-24,4,0
2024-04-24,5,0
2024-04-24,6,0
2024-04-24,7,0
2024-04-24,8,0
2024-04-24,9,0
2024-04-24,10,0
2024-04-24,11,0
2024-04-24,12,0
2024-04-24,13,0
2024-04-24,14,0
2024-04-24,15,0
2024-04-24,16,0
2024-04-24,17,0
2024-04-24,18,0
2024-04-24,19,0
2024-04-24,20,0
2024-04-24,21,0
2024-04-24,22,0
2024-04-24,23,0
2024-04-25,0,0
2024-04-25,1,0
2024-04-25,2,0
2024-04-25,3,0
2024-04-25,4,0
2024-04-25,5,0
2024-04-25,6,0
2024-04-25,7,0
2024-04-25,8,0
2024-04-25,9,0
2024-04-25,10,0
2024-04-25,11,0
2024-04-25,12,0
2024-04-25,13,0
2024-04-25,14,0
2024-04-25,15,0
2024-04-25,16,0
2024-04-25,17,0
2024-04-25,18,0
2024-04-25,19,0
2024-04-25,20,0
2024-04-25,21,0
2024-04-25,22,0
2024-04-25,23,0
2024-04-26,0,0
2024-04-26,1,0
2024-04-26,2,0
2024-04-26,3,0
2024-04-26,4,0
2024-04-26,5,0
2024-04-26,6,0
2024-04-26,7,0
2024-04-26,8,0
2024-04-26,9,0
2024-04-26,10,0
2024-04-26,11,0
2024-04-26,12,0
2024-04-26,13,0
2024-04-26,14,0
2024-04-26,15,0
2024-04-26,16,0
2024-04-26,17,0
2024-04-26,18,0
2024-04-26,19,0
2024-04-26,20,0
2024-04-26,21,0
2024-04-26,22,0
2024-04-26,23,0
2024-04-27,0,0
2024-04-27,1,0
2024-04-27,2,0
2024-04-27,3,0
2024-04-27,4,0
2024-04-27,5,0
2024-04-27,6,0
2024-04-27,7,0
2024-04-27,8,0
2024-04-27,9,0
2024-04-27,10,0
2024-04-27,11,0
2024-04-27,12,0
2024-04-27,13,0
2024-04-27,14,0
2024-04-27,15,0
2024-04-27,16,0
2024-04-27,17,0
2024-04-27,18,0
2024-04-27,19,0
2024-04-27,20,0
2024-04-27,21,0
2024-04-27,22,0
2024-04-27,23,0
2024-04-28,0,0
2024-04-28,1,0
2024-04-28,2,0
2024-04-28,3,0
2024-04-28,4,0
2024-04-28,5,0
2024-04-28,6,0
2024-04-28,7,0
2024-04-28,8,0
2024-04-28,9,0
2024-04-28,10,0
2024-04-28,11,0
2024-04-28,12,0
2024-04-28,13,0
2024-04-28,14,0
2024-04-28,15,0
2024-04-28,16,0
2024-04-28,17,0
2024-04-28,18,0
2024-04-28,19,0
2024-04-28,20,0
2024-04-28,21,0
2024-04-28,22,0
2024-04-28,23,0
2024-04-29,0,0
2024-04-29,1,0
2024-04-29,2,0
2024-04-29,3,0
2024-04-29,4,0
2024-04-29,5,0
2024-04-29,6,0
2024-04-29,7,0
2024-04-29,8,0
2024-04-29,9,0
2024-04-29,10,0
2024-04-29,11,0
2024-04-29,12,0
2024-04-29,13,0
2024-04-29,14,0
2024-04-29,15,0
2024-04-29,16,0
2024-04-29,17,0
2024-04-29,18,0
2024-04-29,19,0
2024-04-29,20,0
2024-04-29,21,0
2024-04-29,22,0
2024-04-29,23,0
2024-04-30,0,0
2024-04-30,1,0
2024-04-30,2,0
2024-04-30,3,0
2024-04-30,4,0
2024-04-30,5,0
2024-04-30,6,0
2024-04-30,7,0
2024-04-30,8,0
2024-04-30,9,0
2024-04-30,10,0
2024-04-30,11,0
2024-04-30,12,0
2024-04-30,13,0
2024-04-30,14,0
2024-04-30,15,0
2024-04-30,16,0
2024-04-30,17,0
2024-04-30,18,0
2024-04-30,19,0
2024-04-30,20,0
2024-04-30,21,0
2024-04-30,22,0
2024-04-30,23,0
2024-05-01,0,0
2024-05-01,1,0
2024-05-01,2,0
2024-05-01,3,0
2024-05-01,4,0
2024-05-01,5,0
2024-05-01,6,0
2024-05-01,7,0
2024-05-01,8,0
2024-05-01,9,0
2024-05-01,10,0
2024-05-01,11,0
2024-05-01,12,0
2024-05-01,13,0
2024-05-01,14,0